NCT03005223Unknown1 期
Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers
Daewoong Pharmaceutical Co. LTD.0 个研究点目标入组 52 人开始时间: 2017年1月4日最近更新:
适应症
干预措施
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 52
- 主要终点
- Maximum Plasma Concentration (Cmax)
研究概览
简要总结
A randomized, open label, crossover study to explore drug-drug interactions between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 45 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Accepts healthy volunteers
排除标准
- •Who has allergy to investigational product
研究组 & 干预措施
Study effect of DWC20163 on DWC20155/DWC20156 PK
Experimental
To study effect of DWC20163 on DWC20155/DWC20156 PK
干预措施: Co-administration of DWC20155/DWC20156 (Drug)
Study effect of DWC20163 on DWC20155/DWC20156 PK
Experimental
To study effect of DWC20163 on DWC20155/DWC20156 PK
干预措施: DWC20163 (Drug)
Study effect of DWC20155/DWC20156 on DWC20163 PK
Experimental
To study effect of DWC20155/DWC20156 on DWC20163 PK
干预措施: Co-administration of DWC20155/DWC20156 (Drug)
Study effect of DWC20155/DWC20156 on DWC20163 PK
Experimental
To study effect of DWC20155/DWC20156 on DWC20163 PK
干预措施: DWC20163 (Drug)
结局指标
主要结局
Maximum Plasma Concentration (Cmax)
时间窗: 0 ~ 24 hours
Area under the time versus plasma concentration curve (AUC)
时间窗: 0 ~ 24 hours
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy VolunteersHealthyNCT02947139Daewoong Pharmaceutical Co. LTD.53
已完成
1 期
Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy VolunteersHealthyNCT02952755Daewoong Pharmaceutical Co. LTD.45
已完成
1 期
Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy SubjectsHealthyNCT02704559Daewoong Pharmaceutical Co. LTD.40
终止
3 期
Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With GastritisGastritisNCT03184415Daewoong Pharmaceutical Co. LTD.230
已完成
1 期
Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult SubjectsInfection, Human Immunodeficiency VirusNCT02082808ViiV Healthcare12